Prev Arrow Stocks

Align Technology Inc. ($ALGN) Stock Forecast: Up 6.0% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Align Technology Inc.?

Align Technology (ALGN) Market: Align Technology is a leading company in the clear aligner market known for its Invisalign product. The company has been taking strategic steps to enhance its market position and facilitate future growth.

Why is Align Technology Inc. going up?

ALGN stock is up 6.0% on Mar 17, 2026 16:35

  • Analysts have upgraded Align Technology from Equal-Weight to Overweight, setting a price target of $200. This upgrade signifies a higher level of confidence in the company's market standing and its potential for future success.
  • Despite concerns about sluggish organic revenue growth and difficulties in the Asia Pacific region, Align Technology has shown strong performance, including impressive Q4 results and outperforming the Nasdaq. These factors have contributed to its positive market movement.
  • By organizing the Southeast Asia Forum to address dental innovation and trends, Align Technology is demonstrating its dedication to advancing dental health and strengthening its presence in the region. This initiative has bolstered investor optimism about the company's growth prospects.
  • The underperformance of Cooper Companies (COO) in comparison to Align Technology and the overall market might have prompted investors to shift their focus towards Align Technology, thereby fueling its positive market trend.

ALGN Price Chart

ALGN Technical Analysis

ALGN News

ALGN: Barclays Upgrades Align Technology to Overweight with a $200 Target | ALGN Stock News

Barclays has upgraded Align Technology (ALGN) from Equal-Weight to Overweight, maintaining a price target of $200. This upgrade reflects Barclays' increased confidence in the company's market position and future performance. Align Technology, known for its Invisalign product, holds a dominant position in the clear aligner market.

https://www.gurufocus.com/news/8719051/algn-barclays-upgrades-align-technology-to-overweight-with-a-200-target-algn-stock-news

0 Missing News Article Image ALGN: Barclays Upgrades Align Technology to Overweight with a $200 Target | ALGN Stock News

Is Cooper Companies Stock Underperforming the Dow?

Cooper Companies (COO) stock has been underperforming the Dow Jones Industrials Average and its peer, Align Technology, Inc. (ALGN). COO's stock is down 20.9% from its 52-week high, declined 12.3% over the past three months, and 12.5% over the past year, while the DOWI gained 13.2% in the last year. Despite mixed Q1 2026 earnings, analysts have a "Moderate Buy" rating with a 27.8% upside potential.

https://www.inkl.com/news/is-cooper-companies-stock-underperforming-the-dow-8000ae92-6bd6-419a-af0f-b74fb92c72c4

1 News Article Image Is Cooper Companies Stock Underperforming the Dow?

Is Cooper Companies Stock Underperforming the Dow?

The Cooper Companies, Inc. (COO) has a market capitalization of $13.9 billion, but its stock has seen a significant decline, falling 20.9% from its 52-week high and 12.3% over the past three months. This underperformance contrasts sharply with the Dow Jones Industrials Average ($DOWI), which gained 13.2% over the past year. COO's recent Q1 2026 earnings showed mixed results, with revenue meeting estimates and EPS beating them, but concerns over weak organic revenue growth and challenges in the Asia Pacific region led to a further stock drop.

https://www.barchart.com/story/news/792299/is-cooper-companies-stock-underperforming-the-dow

2 News Article Image Is Cooper Companies Stock Underperforming the Dow?

Is Align Technology Stock Outperforming the Nasdaq?

Align Technology, Inc. (ALGN), a large-cap medical device company known for its Invisalign system, has recently outperformed the Nasdaq Composite ($NASX) over the past three months and year-to-date. The company's stock has risen 4% in the last three months, despite a 3.2% drop in the Nasdaq, and is up 8.5% YTD compared to Nasdaq's 3.7% fall. This strong performance follows robust Q4 results, which exceeded analyst expectations for both revenue and adjusted EPS, leading to a "Moderate Buy" consensus rating from analysts.

https://www.inkl.com/news/is-align-technology-stock-outperforming-the-nasdaq

3 News Article Image Is Align Technology Stock Outperforming the Nasdaq?

Southeast Asia Forum advances dental innovation, Align Technology convenes medical experts

Align Technology recently hosted the Southeast Asia Forum in Ho Chi Minh City, Vietnam, bringing together dental professionals to discuss innovation and emerging trends in the industry. This event is part of Align Technology's ongoing strategy to strengthen its regional presence and reinforce its leadership in dental technology. The company emphasized its commitment to advancing dental health and promoting early dental habits, aligning with its broader initiatives for professional collaboration.

https://tradersunion.com/news/companies/show/1711915-align-southeast-asia-forum/

4 Missing News Article Image Southeast Asia Forum advances dental innovation, Align Technology convenes medical experts

Align Technology Inc. Price History

06.01.2026 - ALGN Stock was up 5.1%

  • A higher price target of $220 set by Piper Sandler for Align Technology post a robust Q4 showing, with revenue reaching $1.048 billion and $3.29 EPS, has bolstered investor confidence, resulting in a positive trend in the stock.
  • Record revenue achieved by the company in Q4 and fiscal 2025, attributed to a significant increase in Clear Aligner case volumes worldwide, signals its strong market position and growth prospects, further elevating investor optimism.
  • Despite negative earnings forecasts, Align Technology's strong performance and favorable 2026 outlook demonstrate its adept navigation of challenges and effective capitalization on market opportunities, contributing to the upward momentum in the market.

13.01.2026 - ALGN Stock was down 5.9%

  • The bearish movement in ALGN stock today might be linked to profit-taking by institutional investors like Candriam S.C.A. and Savant Capital LLC, who have recently decreased their holdings in the company.
  • Despite exceeding quarterly earnings and revenue expectations, market sentiments could be influenced by analysts' concerns regarding potential margin dilution from new technologies, surfaced during the Q4 earnings call.
  • Ongoing legal disputes with Angelalign Technology Inc. concerning patent infringement and the uncertainty surrounding a preliminary European court ruling on software features could be exerting downward pressure on the stock.
  • While the collaboration with the University of Bern for the Oral Health Study signals a promising avenue for market enlargement, investors could be exercising caution due to uncertainties about immediate sales impact and potential pricing challenges in public health programs.

24.01.2026 - ALGN Stock was up 5.2%

  • ALGN stock saw a significant bullish movement recently.
  • The company's strategic focus on digital workflows, international expansion, and targeting large dental networks appears to have excited investors.
  • The integration of Align Technology's iTero intraoral scanners with Henry Schein One's Dentrix practice management platforms is viewed positively for streamlining digital workflows in dental practices, potentially boosting long-term profitability.
  • Align Technology's attention to children's early dental habits demonstrates its dedication to promoting oral health, which could enhance its brand reputation and customer loyalty.

10.02.2026 - ALGN Stock was up 5.0%

  • Fieldview Capital Management LLC and Rhenman & Partners Asset Management AB acquiring additional shares of ALGN indicate confidence in the company's future prospects, contributing to the bullish movement.
  • The robust growth of the Invisible Orthodontic Appliance Market, in which Align Technology is a key player, is driving investor optimism and interest in the stock.
  • Despite recent share price pullbacks, ALGN's strong earnings performance, expanding clinical indications for Invisalign, and expected double-digit earnings growth are factors supporting the bullish trend.
  • The company's higher-than-industry-average P/E ratio and potential valuation risk if market sentiment shifts highlight the need for investors to monitor market dynamics closely despite the current positive momentum.

03.11.2025 - ALGN Stock was up 5.1%

  • ALGN experienced a strong bullish movement today, driven by several positive developments:
  • The launch of new aligner options and direct fabrication technology is expected to drive growth and margin gains for the company.
  • Expansion into new markets like South Africa and the Philippines with innovative digital dentistry solutions is enhancing ALGN's global presence.
  • The company's focus on digital innovation, patient engagement, and personalized treatment journeys is resonating well with practitioners and patients alike.
  • Despite a recent share price jump and positive news flow, there is still a debate about the stock's valuation, with some suggesting it may be undervalued due to expanding clinical indications and increased adoption by dentists.

12.01.2026 - ALGN Stock was down 5.1%

  • ALGN surpassed earnings and revenue projections for the quarter but faced a downward trend in the market.
  • Reductions in ownership stakes by institutional investors like Candriam S.C.A. and Savant Capital LLC may have influenced the negative market sentiment towards ALGN.
  • Analysts' scrutiny of average selling prices and potential profit dilution from new technologies during the earnings briefing likely sparked concerns among investors, impacting the stock's performance.
  • Despite the current market pessimism, the optimistic forecast for growth in the global dental impression systems market, attributed to technological progress and rising demand, could signify a favorable long-term outlook for ALGN.

05.01.2026 - ALGN Stock was up 10.2%

  • The company reported better-than-expected Q4 2025 earnings and revenue, with record revenues and clear aligner volumes, leading to a significant surge in its stock price.
  • Despite the company's gross and operating margins contracting due to increased costs and expenses, investors were still impressed by the overall performance and outlook for 2026 revenue growth.
  • The positive outlook for the company, driven by strategic priorities like international expansion and increased orthodontic utilization, contributed to the bullish sentiment surrounding ALGN stock.
  • The market's enthusiastic response to the earnings report and optimistic projections reflects investors' confidence in the company's growth potential and ability to navigate the dynamic macro environment.

03.01.2026 - ALGN Stock was down 5.2%

  • The stock of Align Technology (ALGN) recently saw a significant decrease, potentially influenced by various factors:
  • Historical patterns of missing revenue estimates in previous quarters may have caused investor uncertainty and selling pressure, despite the current expectations of revenue growth and earnings per share.
  • A partnership with the University of Bern for a notable epidemiological study on oral health trends in Switzerland, though enhancing the company's reputation, may not have yielded immediate benefits to bolster investor confidence.
  • Efforts to support healthcare research and initiatives, although laudable, might not have directly translated into immediate financial gains, contributing to a negative investor outlook.
  • General market conditions and sector-specific influences could have also affected ALGN stock's decline, as overall market trends can impact individual stock performance.

17.02.2026 - ALGN Stock was up 6.0%

  • Analysts have upgraded Align Technology from Equal-Weight to Overweight, setting a price target of $200. This upgrade signifies a higher level of confidence in the company's market standing and its potential for future success.
  • Despite concerns about sluggish organic revenue growth and difficulties in the Asia Pacific region, Align Technology has shown strong performance, including impressive Q4 results and outperforming the Nasdaq. These factors have contributed to its positive market movement.
  • By organizing the Southeast Asia Forum to address dental innovation and trends, Align Technology is demonstrating its dedication to advancing dental health and strengthening its presence in the region. This initiative has bolstered investor optimism about the company's growth prospects.
  • The underperformance of Cooper Companies (COO) in comparison to Align Technology and the overall market might have prompted investors to shift their focus towards Align Technology, thereby fueling its positive market trend.

17.02.2026 - ALGN Stock was up 6.3%

  • The recent Southeast Asia Forum showcased (ALGN)'s dedication to dental innovation and collaboration with medical experts, boosting investor confidence in its leadership in the dental technology sector.
  • The positive market outlook for digital dentistry, with its rapid expansion and potential, may have influenced the bullish movement in (ALGN)'s stock. Investors seem optimistic about the company's growth in this thriving sector.
  • While some dental companies face performance challenges, (ALGN)'s strategic focus on advancing dental health through initiatives like the Southeast Asia Forum has positioned it well in the market. This commitment to innovation likely contributed to today's bullish performance.

30.09.2025 - ALGN Stock was up 10.1%

  • ALGN experienced a significant increase in its stock price today following the release of its Q3 earnings, which exceeded both earnings and revenue projections.
  • The earnings surpassed expectations by +10.13% and revenue by +2.49%, highlighting the company's robust financial performance and strong market demand for its products.
  • Investor sentiment appears positive regarding ALGN's future growth potential, driven by its innovative dental solutions and leading position in clear aligner technology.
  • The outperformance in financial results suggests that ALGN is effectively leveraging the growing interest in orthodontic treatments, establishing a favorable position for its stock in the market.

30.09.2025 - ALGN Stock was up 5.4%

  • ALGN stock notably surged in today's trading.
  • The remarkable Q3 earnings and revenue exceeded expectations by a substantial margin, bolstering market confidence.
  • However, despite the positive financial results, investors may have been unsettled by the considerable decrease in margins, potentially affecting the stock's performance.
  • Investors are keenly observing upcoming developments to evaluate Align Technology's ability to sustain its growth momentum while addressing margin concerns.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.